Senti Biosciences Holdings (SNTI) Net Cash Flow (2021 - 2025)

Senti Biosciences Holdings' Net Cash Flow history runs 5 years deep, the most recent figure standing at $4.2 million for Q4 2025.

• In Q4 2025, Net Cash Flow fell 88.97% year-over-year to $4.2 million; the TTM figure through Dec 2025 stood at -$31.9 million (down 357.68% YoY), while the FY2025 annual figure was -$31.9 million, down 357.68% from the prior year.
• Net Cash Flow was $4.2 million for Q4 2025 at Senti Biosciences Holdings, up from -$9.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $101.7 million in Q2 2022 to a low of -$57.2 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$1.9 million across 5 years, with a median of -$6.4 million in 2023.
• Biggest YoY gain for Net Cash Flow was 9167.98% in 2022; the steepest drop was 6537.26% in 2022.
• A 5-year view of Net Cash Flow shows it stood at $889323.0 in 2021, then sank by 6537.26% to -$57.2 million in 2022, then soared by 88.86% to -$6.4 million in 2023, then surged by 692.08% to $37.8 million in 2024, then tumbled by 88.97% to $4.2 million in 2025.
• The last three Net Cash Flow figures came in at $4.2 million (Q4 2025), -$9.3 million (Q3 2025), and -$12.2 million (Q2 2025), per Business Quant data.